Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

TARO

Taro Pharmaceutical Industries

Jun 07 • 04:00PM ET

42.77

Dollar change -0.08
Percentage change -0.19	%

Healthcare • Drug Manufacturers - Specialty & Generic • Israel • NYSE

Stock Detail • Compare Perf. • Financials • Options Chain • Save to Portfolio • Create Alert

Held by: IWM IWN IEFA IZRL DFAC SCZ VTWO PRFZ BSMC EIS

Scroll to Statements

Index	RUT	P/E	29.84	EPS (ttm)	1.43	Insider Own	78.48%	Shs Outstand	37.58M	Perf Week	-0.12%
Market Cap	1.61B	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	8.09M	Perf Month	1.16%
Income	53.87M	PEG	-	EPS next Q	-	Inst Own	12.76%	Short Float	0.91%	Perf Quarter	1.76%
Sales	629.18M	P/S	2.55	EPS this Y	-	Inst Trans	0.49%	Short Ratio	2.52	Perf Half Y	16.41%
Book/sh	47.34	P/B	0.90	EPS next Y	-	ROA	2.51%	Short Interest	0.07M	Perf Year	9.72%
Cash/sh	23.40	P/C	1.83	EPS next 5Y	-12.95%	ROE	3.06%	52W Range	32.67 - 45.76	Perf YTD	2.37%
Dividend Est.	-	P/FCF	20.19	EPS past 5Y	-27.64%	ROI	3.03%	52W High	-6.53%	Beta	0.59
Dividend TTM	-	Quick Ratio	3.04	Sales past 5Y	-0.89%	Gross Margin	52.11%	52W Low	30.92%	ATR (14)	0.19
Dividend Ex-Date	Dec 10, 2018	Current Ratio	3.61	EPS Y/Y TTM	111.70%	Oper. Margin	3.42%	RSI (14)	57.27	Volatility	0.22% 0.36%
Employees	1554	Debt/Eq	0.00	Sales Y/Y TTM	9.81%	Profit Margin	8.56%	Recom	3.00	Target Price	43.00
Option/Short	Yes / Yes	LT Debt/Eq	0.00	EPS Q/Q	118.16%	Payout	0.00%	Rel Volume	1.08	Prev Close	42.85
Sales Surprise	5.69%	EPS Surprise	29.03%	Sales Q/Q	12.52%	Earnings	May 20 AMC	Avg Volume	29.15K	Price	42.77
SMA20	0.51%	SMA50	0.92%	SMA200	6.92%	Trades		Volume	31,370	Change	-0.19%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-18-24	Downgrade	H.C. Wainwright	Buy → Neutral	$43
Jul-27-20	Reiterated	H.C. Wainwright	Buy	$96 → $82
Feb-04-20	Reiterated	H.C. Wainwright	Buy	$110 → $94
Nov-05-19	Reiterated	H.C. Wainwright	Buy	$105 → $110
Mar-12-18	Initiated	H.C. Wainwright	Buy	$124
May-23-17	Downgrade	Credit Suisse	Outperform → Neutral

May-23-24 08:10AM	Taro Shareholders Approve Merger with Sun Pharma (PR Newswire)
May-20-24 09:53PM	TARO Stock Earnings: Taro Pharmaceutical Indus Reported Results for Q4 2024 (InvestorPlace)
05:26PM	Taro: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
05:16PM	Taro Pharmaceutical Industries Fiscal Q4 Earnings, Revenue Rise (MT Newswires)
05:00PM	Taro Provides Results for Year Ended March 31, 2024 (Business Wire)
09:00AM	Loading…
May-15-24 09:00AM	Taro to Release Full Year Results on May 20, 2024 (Business Wire)
May-08-24 09:07AM	Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Taro Shareholders Vote FOR Taro Sun Pharma Merger (Business Wire)
Apr-15-24 08:00AM	Taro Announces Extraordinary General Meeting and Ordinary Class Meeting of Shareholders for Approval of Merger with Sun Pharmaceutical Industries Ltd. (Business Wire)
Mar-07-24 12:00AM	Chemical Linked to Cancer Found in Acne Creams Including Proactiv, Clearasil (Bloomberg)
Mar-06-24 12:30PM	Taro Expands Branded Over-the-Counter Portfolio in U.S. with the Launch of FeverAll Liquid Oral Acetaminophen for Children Ages 2-11 (PR Newswire)
Jan-30-24 01:41PM	SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates PGTI, TARO, ANSS (GlobeNewswire)
01:18PM	Kuehn Law Encourages PGTI, TAST, TARO, and ANSS Investors to Contact Law Firm (PR Newswire)
07:00AM	Krensavage Asset Management Remains Opposed to Sun's Predatory Bid for Taro (PR Newswire)
Jan-29-24 11:01PM	SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates ANSS, TARO, MDC (PR Newswire)
Jan-25-24 05:13PM	Taro: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
05:06PM	Loading…
05:06PM	Taro Provides Results for December 31, 2023 (Business Wire)
08:03AM	SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates AMAM, HARP, JNPR, TARO (GlobeNewswire)
Jan-23-24 02:45PM	SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates TAST, MDC, TARO, SOLO (PR Newswire)
10:30AM	Kuehn Law Encourages TAST, ANSS, PGTI, and TARO Investors to Contact Law Firm (GlobeNewswire)
Jan-20-24 11:29AM	SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates TARO, MDC, TCN (GlobeNewswire)
Jan-19-24 04:15PM	Taro to Release Third Quarter Results on January 25, 2024 (Business Wire)
Jan-18-24 01:52PM	SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates TARO, MDC, PGTI, VIA (PR Newswire)
Jan-17-24 04:30PM	Taro Announces Merger Agreement with Sun Pharma (PR Newswire)
Oct-26-23 05:12PM	Taro: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
05:00PM	Taro Provides Results for September 30, 2023 (Business Wire)
Oct-19-23 04:30PM	Taro to Release Second Quarter Results on October 26, 2023 (Business Wire)
Jul-27-23 05:32AM	Taro: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
Jul-26-23 08:36PM	Taro Provides Results for the Quarter Ended June 30, 2023 (Business Wire)
Jul-19-23 04:00PM	Taro to Release First Quarter Results on July 26, 2023 (Business Wire)
07:00AM	Krensavage Asset Management Opposes Sun's Lowball Bid for Taro (PR Newswire)
09:00AM	Loading…
Jun-30-23 09:00AM	Taro Annual Report on Form 20-F Available For Fiscal Year Ended March 31, 2023 (Business Wire)
May-30-23 12:25PM	Why Shares of Taro Pharmaceutical Are Rising Tuesday (Motley Fool) +22.83%
May-23-23 07:28PM	Taro: Fiscal Q4 Earnings Snapshot (AP Finance)
07:00PM	Taro Provides Results for Year Ended March 31, 2023 (Business Wire)
May-18-23 04:46PM	Taro to Release Full Year Results on May 23, 2023 (Business Wire)
Apr-17-23 01:35PM	The past five years for Taro Pharmaceutical Industries (NYSE:TARO) investors has not been profitable (Simply Wall St.)
Jan-27-23 06:01AM	Taro Pharmaceutical Industries Third Quarter 2023 Earnings: Misses Expectations (Simply Wall St.)
Jan-24-23 05:43PM	Taro Provides Results for December 31, 2022 (Business Wire)
Jan-19-23 05:02PM	Taro to Release Third Quarter Results on January 24, 2023 (Business Wire)
Oct-27-22 07:55PM	Taro Pharmaceutical (TARO) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
06:39PM	Taro Provides Results for September 30, 2022 (Business Wire)
Oct-24-22 12:37PM	Taro to Release Second Quarter Results on October 27, 2022 (Business Wire)
Oct-12-22 10:58AM	The five-year shareholder returns and company earnings persist lower as Taro Pharmaceutical Industries (NYSE:TARO) stock falls a further 8.9% in past week (Simply Wall St.)
Aug-11-22 06:17PM	Taro Pharmaceuticals Inc. Issues Voluntary Type I Recall of Taro-Zoledronic Acid Injection, 5 mg/100 mL, 100 mL Vial Due to Particulate Matter Over Specified Requirements (Business Wire)
Jul-27-22 07:05PM	Taro Pharmaceutical (TARO) Lags Q1 Earnings Estimates (Zacks)
05:28PM	Taro Provides Results for the Quarter Ended June 30, 2022 (Business Wire)
Jul-26-22 04:10PM	Taro Annual Report on Form 20-F Available For Fiscal Year Ended March 31, 2022 (Business Wire)
03:37PM	Taro to Release First Quarter Results on July 27, 2022 (Business Wire)
Jul-06-22 06:10AM	What Kind Of Shareholders Hold The Majority In Taro Pharmaceutical Industries Ltd.'s (NYSE:TARO) Shares? (Simply Wall St.)
May-26-22 07:00PM	Taro Provides Results for the Year Ended March 31, 2022 (Business Wire)
May-23-22 05:35PM	MEI Pharma, Inc. (MEIP) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
May-20-22 07:00PM	Taro to Announce Full Year Results on May 26, 2022 (Business Wire)
May-17-22 08:15AM	MediWound (MDWD) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
May-16-22 09:05AM	PolarityTE, Inc. (PTE) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
May-13-22 09:55AM	ProPhase Labs, Inc. (PRPH) Tops Q1 Earnings and Revenue Estimates (Zacks)
May-12-22 08:15AM	CASI Pharmaceuticals, Inc. (CASI) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
May-05-22 10:29AM	Investors in Taro Pharmaceutical Industries (NYSE:TARO) have unfortunately lost 61% over the last five years (Simply Wall St.)
08:45AM	Radius Health (RDUS) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
May-04-22 08:45AM	Neurocrine Biosciences (NBIX) Lags Q1 Earnings Estimates (Zacks)
Feb-28-22 06:19PM	Taro Completes Acquisition of Alchemee (Business Wire)
Feb-22-22 09:23AM	Taro to Acquire Alchemee From Galderma (Business Wire)
Jan-27-22 07:15PM	Taro Pharmaceutical (TARO) Q3 Earnings and Revenues Miss Estimates (Zacks)
05:00PM	Taro Provides Results for December 31, 2021 (Business Wire)
Jan-25-22 08:11AM	Is The Market Rewarding Taro Pharmaceutical Industries Ltd. (NYSE:TARO) With A Negative Sentiment As A Result Of Its Mixed Fundamentals? (Simply Wall St.)
Jan-20-22 08:45PM	Taro to Announce Third Quarter Results on January 27, 2022 (Business Wire)
Jan-19-22 03:01PM	Taro Pharmaceutical (TARO) Earnings Expected to Grow: Should You Buy? (Zacks)
Jan-05-22 07:48AM	Taro (TARO) Surges 6.6%: Is This an Indication of Further Gains? (Zacks)
Dec-01-21 05:05PM	Taro Appoints New Chief Financial Officer (Business Wire)
Nov-15-21 12:15PM	Is Taro Pharmaceutical (TARO) A Great Investment Choice? (Insider Monkey)
Oct-28-21 06:45PM	Taro Pharmaceutical (TARO) Lags Q2 Earnings and Revenue Estimates (Zacks)
05:15PM	Taro Provides Results for September 30, 2021 (Business Wire)
Oct-27-21 11:18AM	Taro Pharmaceutical Industries (NYSE:TARO) investors are sitting on a loss of 32% if they invested five years ago (Simply Wall St.)
Oct-21-21 01:01PM	Taro to Announce Second Quarter Results on October 28, 2021 (Business Wire)
Oct-20-21 03:03PM	Earnings Preview: Taro Pharmaceutical (TARO) Q2 Earnings Expected to Decline (Zacks)
Jul-29-21 07:44AM	Does The Market Have A Low Tolerance For Taro Pharmaceutical Industries Ltd.'s (NYSE:TARO) Mixed Fundamentals? (Simply Wall St.)
Jul-27-21 08:45PM	Taro Pharmaceutical (TARO) Q1 Earnings and Revenues Beat Estimates (Zacks)
07:28PM	Taro Provides Results for Quarter Ended June 30, 2021 (Business Wire)
Jul-20-21 09:05PM	Taro to Announce First Quarter Results on July 27, 2021 (Business Wire)
Jul-19-21 06:49AM	Taro Pharma (TARO) Sees Hammer Chart Pattern: Time to Buy? (Zacks)
Jul-14-21 05:54PM	Taro Announces Resignation of Chief Financial Officer (Business Wire)
Jun-18-21 10:00AM	Taro Annual Report on Form 20-F Available For Fiscal Year Ended March 31, 2021 (Business Wire)
May-19-21 05:30PM	Taro Provides Results for the Year Ended March 31, 2021 (Business Wire)
May-12-21 05:58PM	Taro to Announce Full Year Results on May 19, 2021 (Business Wire)
Mar-09-21 05:37AM	Taro Pharmaceutical Industries' (NYSE:TARO) Shareholders Are Down 44% On Their Shares (Simply Wall St.)
Jan-27-21 05:46PM	Taro Provides Results for December 31, 2020 (Business Wire) -8.41%
Jan-20-21 08:28PM	Taro to Announce Third Quarter Results on January 27, 2021 (Business Wire)
Dec-12-20 07:48PM	Is TARO A Good Stock To Buy Now? (Insider Monkey)
Oct-29-20 06:00AM	Taro Pharmaceutical Industries Ltd. to Host Earnings Call (ACCESSWIRE)
Oct-28-20 06:45PM	Taro Pharmaceutical (TARO) Q2 Earnings and Revenues Top Estimates (Zacks) -6.40%
05:15PM	Taro Provides Results for September 30, 2020 (Business Wire)
Oct-21-20 06:44PM	Taro to Announce Second Quarter Results on October 28, 2020 (Business Wire)
Sep-28-20 01:01PM	Taro Launches Specialty Generic Deferiprone Tablets, 500mg in the U.S. (Business Wire)
Sep-10-20 03:19PM	What Kind Of Shareholders Own Taro Pharmaceutical Industries Ltd. (NYSE:TARO)? (Simply Wall St.)
Jul-29-20 06:55PM	Taro Pharmaceutical (TARO) Misses Q1 Earnings and Revenue Estimates (Zacks)
05:00PM	Taro Provides Results for Quarter Ended June 30, 2020 (Business Wire)
Jul-23-20 04:32PM	Taro Achieves Global Resolution of DOJ Antitrust Investigations (Business Wire)
Jul-22-20 02:37PM	Taro to Announce First Quarter Results on July 29, 2020 (Business Wire)
Jun-25-20 06:45PM	Hedge Funds Are Selling Taro Pharmaceutical Industries Ltd. (TARO) (Insider Monkey)
Jun-19-20 09:30AM	Taro Annual Report on Form 20-F Available for Fiscal Year Ended March 31, 2020 (Business Wire)
May-29-20 05:41PM	Taro Pharmaceuticals: Strong Balance Sheet and Strong Competition (GuruFocus.com)

Taro Pharmaceutical Industries Ltd. engages in the development, manufacturing and marketing of prescribed and over-the-counter pharmaceutical products in the U.S., Canada and Israel. Its products include semi-solids formulations, such as creams and ointments and other dosage forms such as liquids, capsules and tablets, in the dermatological and topical, cardiovascular, neuropsychiatric and anti-inflammatory therapeutic categories. The company was founded in 1950 and is headquartered in Haifa Bay, Israel.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

TARO

Taro Pharmaceutical Industries

Upgrade your FINVIZ experience